Quality assurance
Organic and Mutagenic Impurities in Pharma
The pursuit of high-quality active substances remains
paramount in the pharmaceutical industry. A critical factor in achieving this goal is meticulous control of impurity content. Evaluating impurities in pharmaceuticals is essential to guarantee both their safety and efficacy. These unintended molecules arise during synthesis, storage, or formulation, and some may harbor potential toxicity.
![](https://qbdgroup.com/wp-content/uploads/One-Vigiliance-ensuring-compliance-and-quality-in-pharmacovigilance-1.png)
Download now
Share with a colleague
Email
LinkedIn
WhatsApp